BACKGROUND: The incidence of diabetes is rising across the world. This global problem significantly affects the economic and social development in the 21st century. If the disease is diagnosed in time, the number of complications as well as the costs of therapy will be lower. Modern technologies permeate all spheres of medicine, and diabetes treatment is no exception. Therefore, the aim of this article is to analyze patients' attitudes to the use of modern technologies in the treatment of diabetes (type 1 diabetes mellitus [T1DM] and type 2 diabetes mellitus [T2DM]). METHODS: A total of 313 respondents from the Czech Republic in the period from June 24, 2015, to July 24, 2015, participated in a questionnaire survey. The target group was diabetics regardless of the type of illness. Collected data were analyzed using descriptive statistical methods, Z-test, and test of independence (Pearson's chi-squared test). RESULTS: Although in other areas mobile applications are used to monitor patients' health condition in ~30% of cases, in the case of diabetes they are used by only 4% of respondents. Approximately 8% of participants use an application, but they do not like it. The rest of the respondents have never used any mobile application. These low figures are due to a lack of knowledge about the availability and possibilities of mobile applications. A positive correlation was proven between technical skills and methods of entering data. Gender and age show only a weak dependency of the method of writing data on their own health condition. Furthermore, the monitored parameters show that patients with T1DM control and know more about their health condition than patients with T2DM, which is reflected, for example, by more frequent blood glucose measurements or larger track of their physical activity. Conversely, the relationship between the associated complications and self-care activities has not been demonstrated. CONCLUSION: Despite the current fast development of modern technologies, these technologies are not frequently used in treating patients. The principal problem lies in patients' low technological knowledge and their higher age, which makes learning new skills, including the use of modern technologies, more difficult.

Department of Economics Faculty of Informatics and Management University of Hradec Kralove Hradec Kralove Czech Republic

Zobrazit více v PubMed

International Diabetes Federation . IDF Diabetes Atlas Sixth edition [online] Belgie: 2013. [Accessed March 2016]. Available from: http://www.diabetesatlas.org/

Maresova P, Mohleska H, Kuca K. Social and family load of Alzheimer’s disease. Appl Econ. 2015;48:1936–1948.

Mohelska H, Maresova P, Valis M, Kuca K. Alzheimer’s disease and its treatment costs: case study in the Czech Republic. Neuropsychiatr Dis Treat. 2015;11:2349–2354. PubMed PMC

European Commission [webpage on the Internet] The Green Paper on Mobile Health (“Health”) European Commission; Brussels: 2014. [Accessed March 2016]. Available from: https://ec.europa.eu/digital-single-market/en/news/green-paper-mobile-health-mhealth.

Ventola CL. Mobile devices and apps for health care professionals: uses and benefits. P T. 2014;39(5):356–364. PubMed PMC

International Diabetes Federation . Global Diabetes Scorecard Tracking Progress for Action. Belgium: 2014. [Accessed March 2016]. Available from: www.idf.org/global-diabetes-scorecard/assets/downloads/Scorecard-29-07-14.pdf.

Stratton IM, Adler AI, Neil HA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321(7258):405–412. PubMed PMC

Rodbard HW, Blonde L, Braithwaite SS, et al. Medical guidelines for clinical practice for the management of diabetes mellitus. Endocr Pract. 2007;13(suppl 1):1–68. PubMed

Gaede P, Lund-Andersen H, Parving HH, Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med. 2008;358(6):580–591. PubMed

Parkin CG, Davison JA. Value of self-monitoring blood glucose pattern analysis in improving diabetes outcomes. J Diabetes Sci Technol. 2009;3(3):500–508. PubMed PMC

Berndt RD, Takenga C, Preik P, et al. Impact of information technology on the therapy of type-1 diabetes: a case study of children and adolescents in Germany. J Pers Med. 2014;4(2):200–217. PubMed PMC

Raiff BR, Dallery J. Internet-based contingency management to improve adherence with blood glucose testing recommendations for teens with type-1 diabetes. J Appl Behav Anal. 2010;43:487–491. PubMed PMC

Årsand E, Tatara N, Østengen G, Hartvigsen G. Wireless and Mobile Technologies Improving Diabetes Self-Management: Handbook of Research on Mobility and Computing: Evolving Technologies and Ubiquitous Impacts. Hershey, PA: IGI global; 2011.

El-Gayar O, Timsina P, Nawar N, Eid W. A systematic review of IT for diabetes self-management: are we there yet? Int J Med Inform. 2013;82(8):637–652. PubMed

UK Prospective Diabetes Study Group Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) Lancet. 1998;352:837–853. PubMed

UK Prospective Diabetes Study Group Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) Lancet. 1998;352:854–865. PubMed

DCCT/EDIC Research Group Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N Engl J Med. 2000;342:381–389. PubMed PMC

Lawson ML, Gerstein HC, Tsui E, Zinman B. Effect of intensive therapy on early macrovascular disease in young individuals with type 1 diabetes. Diabetes Care. 1999;22(suppl 1):B35–B39. PubMed

Van Damme P, Martens L, Van Damme J, et al. Caspase-specific and nonspecific in vivo protein processing during Fas-induced apoptosis. Nat Methods. 2005;2(10):771–777. PubMed

Donald H, Franklin V, Greene AH. The use of mobile phones in dietary assessment in young people with Type 1 diabetes. J Human Nutr Diet. 2009;22(3):256–257.

Chomutare T, Fernandez-Luque L, Arsand E, Hartvigsen G. Features of mobile diabetes applications: review of the literature and analysis of current applications compared against evidence-based guidelines. J Med Internet Res. 2013;13(3):e65. PubMed PMC

Anglada-Martínez H, Rovira-Illamola M, Martin-Conde M, Sotoca-Momblona JM, Codina-Jané C. mHealth intervention to improve medication management in chronically ill patients: analysis of the recruitment process. Postgrad Med. 2016;128(4):427–431. PubMed

Haluzík M, Vrablík M, Herber O. Risk Patient from the Perspective Internist, Diabetologist and General Practitioner. Practicus. 2015. [Accessed August 19, 2015]. pp. 29–34. Available from: http://web.practicus.eu/sites/cz/Documents/Practicus-2015-06/29-Rizikovy-pacient.pdf.

Draessler J. Applied Statistic. Hradec Kralove: Gaudeamus; 2013.

Tenderich A [webpage on the Internet] Our Survey: Diabetes Patients Rank Tech Tools, Quality of Life [online] [Accessed August 19, 2015]. Available from: http://www.healthline.com/diabetesmine/diabetes-patients-rank-biggest-drawbacks-of-technology-tools.

Hofstede J, de Bie J, van Wijngaarden B, Heijmans M. Knowledge, use and attitude towards eHealth among patients with chronic lung diseases. Int J Med Inform. 2014;83(12):967–974. PubMed

Free C, Phillips G, Galli L, et al. The effectiveness of mobile-health technology-based health behaviour change or disease management interventions for health care consumers: a systematic review. PLoS Med. 2013;10(1):e1001362. PubMed PMC

Diabetes Control and Complications Trial (DCCT) Research Group The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977–986. PubMed

Spanakis EG, Chiarugi F, Kouroubali A, et al. Diabetes management using modern information and communication technologies and new care models. Interact J Med Res. 2012;1(2):e8. PubMed PMC

Or C, Tao D. A 3-month randomized controlled pilot trial of a patient-centered, computer-based self-monitoring system for the care of type 2 diabetes mellitus and hypertension. J Med Syst. 2016;40(4):81. PubMed

Medical Device Development Process, and Associated Risks and Legislative Aspects-Systematic Review

Customizing the Types of Technologies Used by Patients With Type 1 Diabetes Mellitus for Diabetes Treatment: Case Series on Patient Experience